Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.
Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H.
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):48-69. doi: 10.1002/ajmg.c.31538. Epub 2017 Feb 1.
PMID:28145611
[Joint hypermobility syndrome].
Carbonell-Bobadilla N, Rodríguez-Álvarez AA, Rojas-García G, Barragán-Garfias JA, Orrantia-Vertiz M, Rodríguez-Romo R.
Acta Ortop Mex. 2020 Nov-Dec;34(6):441-449.
PMID:34020527
The evidence-based rationale for physical therapy treatment of children, adolescents, and adults diagnosed with joint hypermobility syndrome/hypermobile Ehlers Danlos syndrome.
Engelbert RH, Juul-Kristensen B, Pacey V, de Wandele I, Smeenk S, Woinarosky N, Sabo S, Scheper MC, Russek L, Simmonds JV.
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):158-167. doi: 10.1002/ajmg.c.31545.
PMID:28306230
Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
Yew KS, Kamps-Schmitt KA, Borge R.
Am Fam Physician. 2021 Apr 15;103(8):481-492.
PMID:33856167
Joint Hypermobility Syndrome and Membrane Proteins: A Comprehensive Review.